136 related articles for article (PubMed ID: 20575163)
21. Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill.
Blaser A; Padar M; Tang J; Dutton J; Forbes A
Anaesthesiol Intensive Ther; 2019; 51(3):230-239. PubMed ID: 31418255
[TBL] [Abstract][Full Text] [Related]
22. Association of Serum Levels of Adipocyte Fatty Acid-Binding Protein and High-Sensitivity C Reactive Protein with Severity of Acute Ischemic Stroke.
Huang XL
Cell Biochem Biophys; 2015 Jun; 72(2):359-61. PubMed ID: 25548006
[TBL] [Abstract][Full Text] [Related]
23. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
[TBL] [Abstract][Full Text] [Related]
24. The prognostic and risk-stratified value of heart-type fatty acid-binding protein in septic patients in the emergency department.
Chen YX; Li CS
J Crit Care; 2014 Aug; 29(4):512-6. PubMed ID: 24768564
[TBL] [Abstract][Full Text] [Related]
25. Impact of the route of nutrition on gut mucosa in ventilated adults with shock: an ancillary of the NUTRIREA-2 trial.
Piton G; Le Gouge A; Brulé N; Cypriani B; Lacherade JC; Nseir S; Mira JP; Mercier E; Sirodot M; Rigaud JP; Malaquin S; Soum E; Djibre M; Gaudry S; Thévenin D; Reignier J
Intensive Care Med; 2019 Jul; 45(7):948-956. PubMed ID: 31143999
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study.
Kanda T; Tsukahara A; Ueki K; Sakai Y; Tani T; Nishimura A; Yamazaki T; Tamiya Y; Tada T; Hirota M; Hasegawa J; Funaoka H; Fujii H; Hatakeyama K
J Gastroenterol; 2011 Apr; 46(4):492-500. PubMed ID: 21298292
[TBL] [Abstract][Full Text] [Related]
27. Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis.
Chen P; Yuan Y; Wang S; Zhan L; Xu J
Tohoku J Exp Med; 2006 Mar; 208(3):261-6. PubMed ID: 16498235
[TBL] [Abstract][Full Text] [Related]
28. [The value of serum intestinal fatty acid binding protein measurement in discriminating intestinal ischemia in patients with acute abdomen].
Shi H; Wu BY; Liu WH; Su BB; Li TT
Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):690-3. PubMed ID: 23158918
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
Alqahtani MF; Smith CM; Weiss SL; Dawson S; Ralay Ranaivo H; Wainwright MS
PLoS One; 2016; 11(4):e0153645. PubMed ID: 27089280
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin and BISAP score versus C-reactive protein and APACHE II score in early assessment of severity and outcome of acute pancreatitis.
Bezmarević M; Kostić Z; Jovanović M; Micković S; Mirković D; Soldatović I; Trifunović B; Pejović J; Vujanić S
Vojnosanit Pregl; 2012 May; 69(5):425-31. PubMed ID: 22764546
[TBL] [Abstract][Full Text] [Related]
31. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
Iturrino J; Camilleri M; Acosta A; O'Neill J; Burton D; Edakkanambeth Varayil J; Carlson PJ; Zinsmeister AR; Hurt R
JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1089-1095. PubMed ID: 26223941
[TBL] [Abstract][Full Text] [Related]
32. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
33. Non-immunological biomarkers for assessment of villous abnormalities in patients with celiac disease.
Singh A; Verma AK; Das P; Prakash S; Pramanik R; Nayak B; Datta Gupta S; Sreenivas V; Kumar L; Ahuja V; Makharia GK
J Gastroenterol Hepatol; 2020 Mar; 35(3):438-445. PubMed ID: 31498492
[TBL] [Abstract][Full Text] [Related]
34. [Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases].
Funaoka H; Kanda T; Fujii H
Rinsho Byori; 2010 Feb; 58(2):162-8. PubMed ID: 20229815
[TBL] [Abstract][Full Text] [Related]
35. Prediction of reversibility of intestinal mucosal damage after ischemia-reperfusion injury by plasma intestinal fatty acid-binding protein levels in pigs.
Kano H; Okada K; Morimoto K; Bao W; Fukase K; Ito A; Okita Y
Perfusion; 2015 Nov; 30(8):617-25. PubMed ID: 25552274
[TBL] [Abstract][Full Text] [Related]
36. Markers of Intestinal Damage and their Relation to Cytokine Levels in Cardiac Surgery Patients.
Habes QLM; Linssen V; Nooijen S; Kiers D; Gerretsen J; Pickkers P; Scheffer GJ; Kox M
Shock; 2017 Jun; 47(6):709-714. PubMed ID: 28505628
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of serum intestinal fatty acid-binding protein in full-term infants with necrotizing enterocolitis].
Huang-Fu CR; Li P; Tian YF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1125-8. PubMed ID: 25406557
[TBL] [Abstract][Full Text] [Related]
38. Is there a relationship between serum heart- type fatty acid binding protein level and clinical severity in patients with subarachnoid hemorrhage?
Yilman M; Cokluk C; Baydin A; Yardan T; Kati C; Gunay M; Meric M
Turk Neurosurg; 2012; 22(6):695-700. PubMed ID: 23208899
[TBL] [Abstract][Full Text] [Related]
39. Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study.
de Haan JJ; Lubbers T; Derikx JP; Relja B; Henrich D; Greve JW; Marzi I; Buurman WA
Crit Care; 2009; 13(3):R86. PubMed ID: 19505335
[TBL] [Abstract][Full Text] [Related]
40. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound.
Miyoshi T; Onoue G; Hirohata A; Hirohata S; Usui S; Hina K; Kawamura H; Doi M; Kusano KF; Kusachi S; Ninomiya Y
Atherosclerosis; 2010 Jul; 211(1):164-9. PubMed ID: 20193950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
